12,852 resources
Start Prev Rows 7800 - 8000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.168 | Pregnancy Bundle CPT | active | 2021-10 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.169 | Pregnancy Bundle HCPCS | active | 2021-10 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.123 | Pregnancy Related Diagnoses ICD10CM | active | 2021-10 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.124 | Pregnancy Related Diagnoses SNOMED | active | 2021-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.151 | Infecund Not for Contraceptive Reasons Procedures | active | 2022-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.165 | Infecund Not for Contraceptive Reasons SNOMED Procedures | active | 2025-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.76 | Contraceptive Patch RXNORM Medications | active | 2025-04 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.83 | Intrauterine Devices ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.84 | Intrauterine Devices ICD10CM Surveillance | active | 2021-10 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.88 | Intrauterine Device SNOMED Provision Procedures | active | 2021-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.89 | Intrauterine Devices SNOMED Surveillance Procedures | active | 2021-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.91 | Intrauterine Devices ICD10PCS Provision Procedures | active | 2021-10 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.78 | Intrauterine Devices CPT Provision Procedures | active | 2021-10 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.80 | Intrauterine Devices LOINC | active | 2021-10 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.86 | Intrauterine Devices SNOMED Devices | active | 2021-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.79 | Intrauterine Devices HCPCS Devices | active | 2021-10 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.81 | Intrauterine Devices HCPCS Provision Procedures | active | 2021-10 | hl7 | cms | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7157 | Binational Reporting Criteria | active | 2013-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1040 | Specimen Child Role (HL7) | active | 2008-01 | tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4437 | Azithromycin medications | active | 2024-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.198 | Hepatic Medical History | active | 2022-03 | hl7 | sct | ||
| hl7.fhir.us.breast-radiology | R4 | ForeignObjectAbnormalityTypeVS | Foreign Object Abnormality Type ValueSet | active | 2022-12 | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7677 | Form Status (RIBD) | active | 2018-01 | sct oid | |||
| hl7.fhir.us.registry-protocols | R4 | VentricularSupport | VentricularSupport | active | cic | 2023-11 | hl7 | fhir sct | |
| hl7.fhir.us.mcode | R4 | mcode-fab-classification-value-vs | FAB Classification Value | active | cic | 2025-02 | hl7 | sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) | active | 2020-01 | sct tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | ncdrq | All codes used as NCDR questions for CathPCI | active | cic | 2023-11 | hl7 | fhir | |
| hl7.fhir.us.registry-protocols | R4 | MyocardialInfarction | Myocardial Infarction | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | FunctionalCapacity | Functional Capacity | active | cic | 2023-11 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1058 | Vaccine Purchased With Funds | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7690 | GAS Risk Factor (RIBD) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7739 | GAS Lab Test Type (RIBD) | active | 2018-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7685 | GBS Time Period (RIBD) | active | 2018-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7691 | GAS Risk Factor Interval (RIBD) | active | 2018-01 | tho oid | |||
| fhir.mamaToto | R4 | genderVS | Gender | draft | 2025-06 | hl7 | internal | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7908 | Gender (ARLN) | active | 2019-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7763 | Gene Name (TB) | active | 2021-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) | active | 2019-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3243 | Lab Test Finding (Flu) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.836 | Race Category | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.917 | Patient Class (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7843 | Organism (Lyme) | active | 2022-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) | active | 2019-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) | active | 2011-01 | sct tho | |||
| hl7.fhir.us.mcode | R4 | mcode-gleason-grade-group-value-vs | Gleason Grade Value Set | active | cic | 2025-02 | hl7 | sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) | active | 2018-01 | sct tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.179 | Intubation | active | 2022-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.11 | Estrogen Receptor Test for Orserdu | active | 2023-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.13 | HER2 Negative | active | 2023-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type | active | 2025-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.974 | MASLD | active | 2025-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.17 | Metastatic Breast Cancer | active | 2023-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults | active | 2019-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1121.5 | Most/Moderately Effective Contraceptive Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.226 | Systolic Heart Failure | active | 2025-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites | active | 2023-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma | active | 2023-09 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7741 | H Antigens (FDD) | active | 2018-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) | active | 2022-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) | active | 2021-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) | active | 2021-01 | sct tho | |||
| hl7.fhir.us.davinci-vbpr | R4 | hcplan-framework | HCPLAN Framework Categories | trial-use | 1 | cqi | 2025-07 | hl7 | tho |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.32 | HER2 Positive | active | 2023-09 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3369 | Route Of Administration (IIS) | active | 2018-01 | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3232 | HIV Status (PHCR) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7192 | HIV Status (STD) | active | 2019-12 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7256 | Morphologic Abnormalities of Neoplasms | draft | sct | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.809 | Marital Status (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1017 | Nature of Abnormal Test (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3338 | Coding System HL7 2x Table 0396 | active | 2021-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.820 | Expanded Yes No (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.875 | Null Flavor (HL7 V3) | active | 2008-01 | tho | |||
| hl7.fhir.us.vitalsigns | R4 | abnIntNumericNomVS | Abnormal Interpretation Numeric Nominal value set | draft | 2015-04 | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1028 | Processing ID (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1059 | Value Type (HL7) | active | 2015-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.810 | Name Type (HL7) | active | 2011-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.818 | Telecommunication Use Code (HL7) | active | 2018-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.817 | Telecommunication Equipment Type (HL7) | active | 2018-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1029 | Processing Mode (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1055 | Universal ID Type (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.925 | Pharmacy Order Type (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3014 | Source of Comment (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.802 | Administration Device (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.803 | Administration Method (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.961 | Address Type | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.960 | Specimen Additive or Preservative (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.927 | Administrative Sex (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.913 | Admission Type (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.800 | Abnormal Flag (HL7) | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.806 | Allergen Type (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.807 | Allergy Severity (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.912 | Admission Level of Care (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3350 | Alternate Character Set Handling Scheme (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3347 | Alternate Character Sets (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3355 | Authorization Mode (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3339 | Check Digit Scheme (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3337 | Event Type (HL7) | active | 2018-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3349 | Message Structure (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3341 | Message Type (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3351 | Name Assembly Order (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3352 | Name Address Representation (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3354 | Order Type (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3346 | Organizational Name Type (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3021 | Preferred Method of Contact (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3356 | Risk Codes (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3340 | Specimen Action Code (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3353 | TQ Conjunction ID (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3345 | Type of Referenced Data (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3348 | Visit Indicator (HL7) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3362 | Event Type (IIS) | active | 2018-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3364 | Message Type (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3367 | Version ID (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3368 | Order Control Code (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3383 | Quantity Limited Request (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3370 | Administrative Site (IIS) | active | 2019-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3371 | Name Type (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6063 | Universal ID Type (IIS) | active | 2012-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3375 | Action Code (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3376 | Message Structure (IIS) | active | 2010-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7642 | Harvest Classification (FDD) | active | 2017-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7641 | Harvest Region (FDD) | active | 2018-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7470 | Head Circumference Findings | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7827 | Segment Action Code (HL7_2x) | active | 2018-01 | tho | |||
| hl7.fhir.us.directory-query | R4 | HealthcareServiceTypeVS | HealthcareService Type Value Set | active | 2022-12 | hl7 | tho | ||
| hl7.fhir.us.ndh | R4 | HealthcareServiceTypeVS | HealthcareService Type Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) | active | 2021-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3219 | Vaccine Administered (Hepatitis B) | active | 2009-01 | cvx | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3230 | Disease Type (Hepatitis) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) | active | 2021-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.617 | HighICS_LABA_NonFormoterol | active | 2023-11 | hl7 | rx | ||
| signal.core.r4 | R4 | questionnaire-ccars-highest-education-level | Questionnaire CCARS Highest Education Level | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3168 | Education Level | active | 2008-01 | tho | |||
| hl7.fhir.us.breastcancer | R3 | oncology-BreastCarcinomaHistologicTypeVS | BC BreastCarcinomaHistologicTypeVS ValueSet | draft | 2018-08 | hl7 | fhir sct | ||
| signal.core.r4 | R4 | questionnaire-ccars-history-of-issues | Questionnaire CCARS History Of Issues | draft | 1 | pa | hl7 | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1040 | History of hip fracture in parent | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1078 | History of hip fracture in parent | active | 2018-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.29 | Hospice Exclusions Grouping | active | 2023-02 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) | active | 2020-01 | sct tho | |||
| signal.core.r4 | R4 | questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | 1 | pa | hl7 | ||
| hl7.fhir.us.mcode | R4 | mcode-condition-status-trend-vs | Condition Status Trend Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.611 | relatedconditions_Asthma I10 | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.571 | Allergy to house dust mites I10 | active | 2023-08 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.409 | Hypertension I10 | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.38 | relatedconditions_hypertension I10 | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.322 | Angina I10 | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.252 | relatedconditions_Heart failure I10 | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.350 | Coronary artery disease I10 | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.439 | relatedconditions_T2DM I10 | active | 2024-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.325 | Tachyarrhythmia I10 | active | 2023-09 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7705 | ICD Codes (RIBD) | active | 2018-01 | fhir icd | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7356 | Diagnosis (ICD-10 CM) | active | 2020-12 | icd | |||
| hl7.fhir.us.davinci-pct | R4 | PCTDiagnosticCodes | PCT ICD-10 Diagnostic Codes | trial-use | fm | 2025-06 | hl7 | icd | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7371 | Procedure (ICD-10 PCS) | active | 2019-12 | cms | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.119 | Inpatient Falls | active | 2024-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.23 | Coagulation Disorders | active | 2025-02 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.856 | Diagnosis (ICD-9 CM) | active | 2010-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.962 | Procedure (ICD-9 CM) | active | 2010-01 | fhir | |||
| hl7.fhir.us.vrdr | R4 | vrdr-icd10-causes-of-death-vs | ICD10 Causes of Death ValueSet | active | pher | 2024-10 | hl7 | icd | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.88 | Acute Respiratory Failure | active | 2023-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.92 | Degenerative Neurological Disorder | active | 2024-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.93 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2024-01 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.91 | Neuromuscular Disorder | active | 2024-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.89 | Tracheostomy Diagnoses | active | 2022-07 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.136 | Leukemia or Lymphoma | active | 2022-10 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.137 | Liver Disease Moderate to Severe | active | 2022-10 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.20 | Secondary Erythrocytosis Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.79 | Acute Brain or Spinal Injury or Hemorrhage | active | 2024-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.105 | Mechanical Ventilation Procedures | active | 2022-05 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.81 | Extracorporeal Membrane Oxygenation | active | 2024-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.90 | Tracheostomy Procedures | active | 2023-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.86 | Intubation | active | 2022-07 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.41 | All Metastatic Sites ICD910 | active | 2023-10 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.80 | Pulmonary Arterial Thrombectomy | active | 2024-06 | hl7 | cms | ||
| hl7.fhir.us.vr-common-library | R4 | ValueSet-ije-vr | ValueSet - Placeholder ValueSet for Interjurisdictional Exchange (IJE) in Vital Records | active | pher | 2025-05 | hl7 | fhir | |
| fhir.tx.support.r4 | R4 | allergy-intolerance-substance-product-snomed-extended-uv-ips | Allergy intolerance substance product - SNOMED CT extended - IPS | active | 2021-05 | hl7 | sct | ||
| fhir.tx.support.r4 | R4 | allergy-intolerance-substance-product-gps-uv-ips | Allergy-intolerance substance-product - GPS - IPS | active | 2021-05 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3286 | Country Subdivision (ISO 3166-2) | active | 2010-01 | iso | |||
| hl7.fhir.us.insurance-card | R4 | ISOColorVS | C4DIC ISO Color | active | claims | 2024-04 | hl7 | tho | |
| us.nlm.vsac | R4 | 2.16.840.1.113883.10.20.22.5.304 | Organism | active | 2024-06 | hl7 | sct | ||
| fhir.virtually.healthcare | R4 | IdentifierTypeVH | Identifier Type | draft | 2025-07 | hl7 | tho | ||
| fhir.mamaToto | R4 | identifierTypesVS | Identifier Types ValueSet | draft | 2025-06 | hl7 | internal | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.976 | Confidentiality Code (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.999 | Identifier Type | active | 2008-01 | tho | |||
| hl7.fhir.us.davinci-cdex | R4 | cdex-identifier-types | CDex Identifier Types Value Set | trial-use | 2 | claims | 2022-10 | hl7 | tho |
| fhir.nw-gmsa.nhs.uk | R4 | NWIdentifierType | NW IdentifierType | draft | 2025-04 | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7828 | Immunization Profile ID (IIS) | active | 2018-01 | oid | |||
| hl7.fhir.us.carin-bb | R4 | C4BBRelatedClaimRelationshipCodes | C4BB Related Claim Relationship Codes Value Set | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| signal.core.r4 | R4 | questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.993 | Error Severity (HL7) | active | 2018-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.5.301 | Immunization Service Funding Eligibility Value Set | active | 2009-01 | oid | |||
| signal.core.r4 | R4 | questionnaire-dacods-health-insurance-status | Questionnaire DACODS Health Insurance Status | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | questionnaire-dacods-drug-type-code | Questionnaire DACODS Drug Type Code | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | questionnaire-dacods-source-of-income | Questionnaire DACODS Source Of Income | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | questionnaire-dacods-secondary-tertiary-drug-type-code | Questionnaire DACODS Secondary Tertiary Drug Type Code | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | questionnaire-dacods-employment-status | Questionnaire DACODS Employment Status | draft | 1 | pa | hl7 |
FHIR